Rachel Haurwitz is the President and CEO of Caribou Biosciences, a clinical-stage biopharmaceutical company she co-founded in 2011 with Nobel laureate Jennifer Doudna and colleagues Martin Jinek and James Berger. A pioneer in CRISPR commercialization, Haurwitz earned her PhD from UC Berkeley under Doudna's mentorship — she was the first student in the lab to work on CRISPR — and pivoted from academia to industry to bring genome-editing technology to patients. Under her leadership, Caribou has developed a proprietary Cas12a-based platform (chRDNA technology) enabling precise, multiplex genome editing for off-the-shelf allogeneic CAR-T and CAR-NK cell therapies targeting blood cancers and autoimmune diseases. She also co-founded Intellia Therapeutics in 2014 and has been recognized on Forbes 30 Under 30, Fortune 40 Under 40, and featured in Walter Isaacson's bestseller 'The Code Breaker.'
Sampriti Bhattacharyya is the founder and CEO of Navier, the company building America's first all-electric hydrofoiling boat. She grew up in Kolkata, India, arrived in the US at 20 with $200, and went on to earn a PhD in mechanical engineering from MIT. After her first venture — Hydroswarm, an underwater drone startup — she co-founded Navier in 2020 with MIT engineer Reo Baird. Their flagship product, the N30, is a 30-foot, eight-passenger electric foiling yacht that glides four feet above the water at 35 knots, runs 10 times more efficiently than gas-powered boats, and delivered its first customer unit in October 2024. Navier's investors include Google co-founder Sergey Brin and Android co-founder Rich Miner.
Vasiliki 'Vicky' Demas, PhD, is the CEO and founder of identifeye HEALTH, an AI-enabled retinal imaging company that brings specialized eye screening to primary care settings. A chemical engineer by training with a PhD from UC Berkeley and a postdoc at Lawrence Berkeley National Lab, she cut her teeth as a founding member of Google Life Sciences (which became Verily) and helped build foundational technology for GRAIL's Galleri multi-cancer early detection test. At identifeye HEALTH — which she joined in 2021 and rebranded from Tesseract Health — she leads a 38-person team developing a portable, FDA-registered AI retinal camera that lets minimally trained staff detect diabetic retinopathy and systemic disease markers in the same visit patients already make to their primary care doctor.
Alyson Watson is the CEO and Chair of the Board of Woodard & Curran, a Portland, Maine-based integrated science, engineering, design-build, and operations firm specializing in water and environmental challenges. A Stanford-trained chemical engineer and licensed PE, she became the firm's third CEO in 2021 — and its first woman to hold that title — after more than 20 years leading water resources projects and building environmental consulting teams across the western United States. A self-described 'water brat' with roots in the industry, Watson is a passionate advocate for clean water access, outcome-based contracting, and employee ownership, guiding a firm of 1,300 people across 27 offices nationwide.
Anna-Katrina Shedletsky is the CEO and co-founder of Instrumental Inc., a Palo Alto-based AI manufacturing software company she founded in 2015 after six years at Apple—where she spent 300+ days in Chinese factories debugging manufacturing issues for the iPod and led product design for the original Apple Watch. At Instrumental, she is converting those factory-floor battle scars into software that uses AI and cameras to find defects and eliminate waste on electronics assembly lines, with customers including Cisco, Honeywell, Bose, Meta, and Lenovo. The company has raised $80.3M in total funding and was named Fast Company's #2 Most Innovative Manufacturing Company in 2021. She also founded the Women in STEM Mentorship Program (WISMP) at Stanford in 2013, which now spans multiple universities.
Peyton Greenside is the CEO and co-founder of BigHat Biosciences, a San Mateo-based biotech company she co-founded in 2019 with Mark DePristo. A pioneer of deep learning applied to life science, Greenside combined a PhD in Biomedical Informatics from Stanford, an MPhil from Cambridge, and a BA in Applied Math from Harvard into a singular mission: use machine learning and synthetic biology to design safer, more effective antibody therapeutics faster than anyone thought possible. BigHat's Milliner platform generates thousands of unique antibody designs per week, and the company has raised $174M in total funding with pharma partnerships spanning Amgen, Merck, AbbVie, Johnson & Johnson, and Eli Lilly.
Jess Ramos is a data analytics educator, LinkedIn Top Voice, and founder of Big Data Energy - a media and education brand with 500,000+ followers across platforms. With an MSBA from the University of Georgia, she turned a corporate analytics career (peaking at $153K at Crunchbase) into a thriving solo business after being laid off in 2023. She runs a Substack newsletter with 45,000+ subscribers, teaches SQL to 50,000+ students via LinkedIn Learning, and has brand partnerships with IBM, AWS, Snowflake, NFL, and Claude (Anthropic). Her origin story - doubling her salary 110% in 11 months - became a viral moment that built her community of data professionals seeking real, human-centric career guidance.
Emily Oster is a Harvard-trained economist, Brown University professor, and the mind behind ParentData - a platform transforming how millions of parents make decisions. With four consecutive New York Times bestsellers, TIME's 100 Most Influential People recognition, and over a million books sold, she wields data like a scalpel against pregnancy myths and parenting guilt, convincing readers that evidence beats anxiety every time.
Dr. Katelyn Jetelina is an epidemiologist, data scientist, and one of America's most influential science communicators. She founded Your Local Epidemiologist (YLE) in March 2020 as a few sentences to update her UT Health students about COVID-19 - and somehow that turned into a 365,000-subscriber newsletter reaching people in 133 countries with over 500 million total views. Named a TIME100 Most Influential Person in Health, she translates complex public health science into actionable insights twice a week, covering everything from vaccines and bird flu to gun violence and federal health policy. She holds a PhD in Epidemiology and Biostatistics, consults with the CDC, and serves as an adjunct professor at Yale School of Public Health - all while raising two daughters and having visited 50+ countries.